Pacific Biosciences of California PACB Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's unrealized losses on investments (before tax)?
- Pacific Biosciences of California (PACB) reported unrealized losses on investments (before tax) of $263K in Q1 2026.
- How has Pacific Biosciences of California's unrealized losses on investments (before tax) changed year-over-year?
- Pacific Biosciences of California's unrealized losses on investments (before tax) increased by 265.3% year-over-year, from $72K to $263K.
- What is the long-term trend for Pacific Biosciences of California's unrealized losses on investments (before tax)?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's unrealized losses on investments (before tax) has grown at a -94.1% compound annual growth rate (CAGR), from $4.78M to $1K.